Half of Patients With Low-Risk Prostate Cancer Switch From Active Surveillance to Treatment
August 25th 2021Active surveillance, intended to avoid unnecessary treatment and the resulting adverse effects, typically involves regular prostate-specific antigen (PSA) screenings, prostate exams, imaging studies, and repeat biopsies to carefully monitor prostate cancer growth or progression without compromising long-term outcomes.
Read More
Pharmacy Fact: What is the Best-Selling Prescription Drug?
August 20th 2021The pharmaceutical market is massive, clocking in at more than $1.2 trillion in 2020, with an anticipated growth of nearly $22 billion dollars expected in 2021. Examining which drug makes up the most of that revenue, one name pulls far away from the competition.
Read More
Immunotherapy May Be Effective In Certain Patients With Metastatic Colorectal Cancer
August 12th 2021Patients with microsatellite stable (MSS) colorectal cancer, which represents 95% of all metastatic colorectal cancer cases, are more responsive to checkpoint blockade immunotherapy if the patient’s tumors have not spread to the liver.
Read More
Booster Shots for mRNA COVID-19 Vaccines Offer Improved Protection From Variants of Concern
August 12th 2021The investigators found that antibodies generated by a single dose of the Pfizer-BioNTech vaccine was less effective at neutralizing variants of concern, but the second dose dramatically increased responses to virus variants.
Read More
Trastuzumab Deruxtecan Improves Progression-Free Survival for Certain Patients With Breast Cancer
August 11th 2021The Independent Data Monitoring Committee concluded that DESTINY-Breast03 met the primary endpoint of progression-free survival and showed a highly statistically significant and clinically meaningful improvement for patients with human epidermal growth factor receptor 2 (HER2)-positive, unresectable and/or metastatic breast cancer previously treated with trastuzumab and a taxane.
Read More
Multimorbidity, health-related quality of life, and stigma and discrimination continue to be major issues for people living with HIV, including those who have achieved viral suppression, according to a consensus statement from a multidisciplinary panel of HIV experts published in Nature Communications.
Read More
The investigators found that the combination of cemiplimab-rwlc and chemotherapy resulted in a substantial improvement in OS compared to chemotherapy alone for patients with metastatic or locally advanced disease and tumors with either squamous or non-squamous histology and across all programmed death-ligand 1 expression levels.
Read More
Vaccine Hesitancy Largely Driven by Negative Views of Vaccines, Pharmaceutical Industry
August 9th 2021The investigators said that attention-grabbing anti-vaccine arguments, regardless of scientific basis, as well as an overall distrust of the pharmaceutical industry, science, and health providers, seems to be primarily responsible.
Read More
Health Outcomes for Patients With Diabetes, Depression May Be Improved By Antidepressants
August 6th 2021Antidepressants may lower the risk of death and serious complications from diabetes for patients with both diabetes and depression, according to a study published in the Journal of Clinical Endocrinology & Metabolism.
Read More
5-Day Radiation Regimen Safe, Effective for Individuals With Severe Prostate Cancer
August 5th 2021According to the investigators, the findings demonstrate that a 5-day regimen of stereotactic body radiotherapy, a form of external beam radiation therapy that uses a higher dose of radiation, had a 4-year cure rate of 82%.
Read More